News

Tiger BioSciences Enhances Wound Care with Innovative Acquisition

Tiger BioSciences Enhances Wound Care with Innovative Acquisition

Tiger BioSciences Advances Autologous Wound Care Technology

Tiger BioSciences, a leader in regenerative medicine and tissue innovation, has made a significant advancement in its wound care capabilities. The company recently announced that it has acquired cutting-edge Platelet-Rich Fibrin Matrix (PRFM) technology, along with proprietary PRFM tubes and a unique wound dressing platform from Bahia Medical Inc. This strategic move aims to enhance the company's offerings in autologous wound dressing therapy.

Enhancing the Treatment of Chronic Wounds

The newly integrated PRFM system allows clinicians to prepare high-quality autologous platelet concentrates directly at the point of care. This technology is crucial for treating chronic and complex wounds, which often challenge healthcare providers. The advanced dressing features a versatile design, making it suitable for various wound sizes and capable of serving as a wearable patch that activates PRFM on-site, offering a practical solution for patients and clinicians alike.

Commitment to Innovative Solutions

Oliver Burckhardt, Co-CEO of Tiger BioSciences, expressed enthusiasm about the acquisition, noting that it represents a pivotal moment for the company's efforts to diversify its portfolio. Burckhardt emphasized the alignment of this technology with the company's mission to deliver innovative, first-to-market solutions aimed at empowering clinicians and enhancing patient outcomes.

The addition of the PRFM technology not only expands Tiger BioSciences’ capabilities in regenerative medicine but also signifies the company's commitment to providing a comprehensive suite of solutions tailored to meet varied patient needs across all care settings.

A Forward-Thinking Approach to Wound Care

Garrett Grinsfelder, President of Tiger Wound Care, highlighted the excitement surrounding the incorporation of these technologies into the Tiger BioSciences family. This acquisition is anticipated to enhance the support provided to clinicians, equipping them with advanced and intuitive tools designed to raise the standard of care in wound management.

Tiger BioSciences plans to further develop this newly acquired technology through clinical trials, with aspirations of securing 510(k) clearance from the FDA. The ultimate goal is to see these innovations commercially launched by the end of 2026, marking another chapter in the company's journey of growth and excellence.

About Tiger BioSciences

Tiger BioSciences, headquartered in Conshohocken, PA, is a vertically integrated cell and tissue technology company. It specializes in the recovery, processing, development, and distribution of cellular, acellular, and matrix-like products (CAMPS), alongside aesthetic technologies. With a rich heritage in human cell and tissue processing expertise, Tiger BioSciences operates as a tissue recovery agency and innovator in processing, aesthetics device manufacturing, and as a commercial partner to clinicians. The company is dedicated to delivering state-of-the-art solutions catering to the evolving needs of healthcare providers and their patients, enabling transformative treatment options across a wide range of medical applications. Tiger BioSciences is committed to serving patients, providers, and donor families with integrity and compassion.

Frequently Asked Questions

What is the recent acquisition by Tiger BioSciences?

Tiger BioSciences has acquired Platelet-Rich Fibrin Matrix technology and associated products from Bahia Medical Inc. to enhance its wound care capabilities.

How does the PRFM technology benefit clinicians?

The PRFM technology allows clinicians to prepare high-quality autologous platelet concentrates at the point of care, which is crucial for treating chronic wounds.

What are the goals for the acquired technology?

The goal includes completing clinical trials and pursuing 510(k) clearance with plans for a commercial launch by late 2026.

What does Tiger BioSciences specialize in?

Tiger BioSciences specializes in cellular, acellular, and matrix-like products, as well as aesthetic technologies, focusing on regenerative medicine.

What is the mission of Tiger BioSciences?

The mission is to deliver innovative solutions that empower clinicians and improve patient outcomes through advanced medical technologies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 74

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 4

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 2

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 7

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 42

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 5

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 2

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 61

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 5

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Mega Millions Players Await Epic Christmas Jackpot of $825M

Updated Category News Views 149

The Excitement of the Mega Millions Jackpot This holiday season is heating up for Mega Millions players, with the jackpot soaring to an estimated $825 million. After an impressive 28 consecutive rollovers, this thrilling prize is edging closer to the spectacular $1 billion mark, promising festive cheer for many who play the game. Record-Breaking Year for Lottery Fans The...

Continue Reading
Understanding Post-Meal Discomfort and Its Causes

Updated Category News Views 189

The Reality of Post-Meal Discomfort Indulging in our favorite meals brings joy to many of us; however, this pleasure can sometimes lead to unexpected discomfort. A recent survey revealed that close to half of respondents experience gastrointestinal issues after eating. Common complaints include bloating and gas, affecting 74% and 67% of those surveyed, respectively. What...

Continue Reading
Collaboration to Enhance Preconfirmations for Ethereum Rollups

Updated Category News Views 151

Collaboration to Enhance Preconfirmations in Ethereum Rollups Taiko and Commit-Boost have joined forces to pave the way for improved preconfirmation standards for rollups in the Ethereum ecosystem. This partnership marks a significant step forward in optimizing how transactions are processed and confirms the commitment of both organizations to advance Ethereum's...

Continue Reading
Institutional Investor Introduces Innovative Think Tank for Finance

Updated Category News Views 80

Institutional Investor Launches the Asset Management Institute Institutional Investor (II) has made a significant stride in the asset management sector by launching the Asset Management Institute (AMI). This innovative initiative represents the first global think tank specifically tailored for professionals in asset management, fostering a dedicated community for shared...

Continue Reading
Citius Oncology Secures $18M for LYMPHIR Launch and Growth

Updated Category News Views 157

Citius Oncology Secures $18 Million to Enhance Growth Citius Oncology, Inc. (NASDAQ: CTOR) has taken a significant step forward by announcing a concurrent registered direct offering and private placement, aiming to raise $18 million. This bold move is primarily aimed at bolstering the company’s cash position while paving the way for the commercial launch of LYMPHIR™,...

Continue Reading